Pompholyx as a side effect of intravenous immunoglobulin (IVIg)

被引:1
|
作者
Doyle, Claire [1 ]
Eustace, Karen [1 ]
机构
[1] Beaumont Hosp, Dermatol, Dublin, Ireland
关键词
Dermatology; Skin; Drugs and medicines; THERAPY;
D O I
10.1136/bcr-2022-248772
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intravenous immunoglobulin (IVIg) is increasingly used across multiple specialties for the treatment of inflammatory and autoimmune diseases. Cutaneous reactions to IVIg are generally minor. Pompholyx is a common eruption of small vesicles on the palms, soles, and/or lateral aspects of the fingers. It has a multifactorial aetiology but is rarely attributed to being a drug-related side effect. We describe a 43-year-old woman presenting with peripheral sensory neuropathy who developed pompholyx eczema on both palms following treatment with IVIg.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Intravenous immunoglobulin (IVIG) in the treatment of membranoproliferative glomerulonephritis (MPGN).
    Johnson, VL
    Perelstein, EM
    Valacer, DJ
    Spitzer, RE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2642 - A2642
  • [42] Intravenous immunoglobulin (IVIG) for orbital Wegener's granulomatosis
    Wiwatwongwana, Damrong
    Esdaile, John M.
    White, Valerie A.
    Dolman, Peter J.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2012, 47 (01): : 82 - 83
  • [43] INTRAVENOUS IMMUNOGLOBULIN (IVIG) THERAPY OF NEONATAL ALLOIMMUNE GRANULOCYTOPAENIA
    JARVENPAA, AL
    RAJANTIE, J
    ACTA PAEDIATRICA SCANDINAVICA, 1991, 80 (8-9): : 885 - 886
  • [44] Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG)
    Molina, Vered
    Haj-Yahia, Saleem
    Solodeev, Inna
    Levy, Yair
    Blank, Miri
    Shoenfeld, Yehuda
    AUTOIMMUNITY, 2006, 39 (08) : 711 - 717
  • [45] Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-BarrE syndrome
    Rhee, D-Y
    Park, G-H
    Chang, S-E
    Lee, M-W
    Choi, J-H
    Moon, K-C
    Koh, J-K
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (05) : 602 - 604
  • [46] Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation
    Pagnini, I.
    Marino, A.
    Simonini, G.
    Cimaz, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (01) : S170 - S170
  • [47] Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute
    Prabagar, Miglena G.
    Choi, Hyeong-jwa
    Park, Jin-Yeon
    Loh, Sohee
    Kang, Young-Sun
    CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 14 (04) : 361 - 373
  • [48] OPSONIC ACTIVITY OF COMMERCIALLY AVAILABLE INTRAVENOUS IMMUNOGLOBULIN (IVIG) PREPARATIONS
    WEISMAN, LE
    WILSON, SR
    STEVENS, S
    CRUESS, DF
    ANDERSEN, LA
    FISCHER, GW
    PEDIATRIC RESEARCH, 1994, 35 (04) : A306 - A306
  • [49] A SEVERE REACTION TO INTRAVENOUS IMMUNOGLOBULIN (IVIG) AFTER MULTIPLE INFUSIONS
    ASSAAD, A
    LIERL, M
    MARMER, D
    KETTLEHUT, B
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 283 - 283
  • [50] Intravenous immunoglobulin (IVIg) in the management of severe refractory vernal keratoconjunctivitis
    Derriman, L.
    Nguyen, D. Q.
    Ramanan, A. V.
    Dick, A. D.
    Tole, D. M.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (05) : 667 - 669